Potential anti-HIV agents from marine resources: An overview

Marine Drugs

Volumn 8, Issue 12, 2010, Pages 2871-2892

  Vo, Thanh Sang ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

AIDS; Anti HIV agents; Marine resources; Phlorotannins

Indexed keywords

6,6' BIECKOL; 8,8' BIECKOL; AMINOETHYL CHITOSAN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; CALLIPELTIN A; CHITIN; CHITOSAN; CHITOSE OLIGOSACCHARIDE; DIPHLORETHOHYDROXYCARMALOL; EA1 20; EC2 20; FUCAN A; FUCAN B; GRIFFITHSIN; HOMOPHYMINE A; LECTIN; LEUCYLLEUCYLGLUTAMYLTYROSYLSERYLISOLEUCINE; LEUCYLLEUCYLGLUTAMYLTYROSYLSERYLLEUCINE; N CARBOXYMETHYLCHITOSAN N,O SULFATE; NAVICULAN; NEAMPHAMIDE A; PAPUAMIDE A; PAPUAMIDE B; PHLOROTANNIN; POLYSACCHARIDE SULFATE; SULFATED CHITOOLIGOSACCHARIDE; SULFATED GLUCURONOGALACTAN; SULFATED POLYMANNUROGULURONATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIVIRAL ACTIVITY; BROWN ALGA; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; IN VITRO STUDY; MARINE SPECIES; NONHUMAN; PROTEIN GLYCOSYLATION; RED ALGA; REVIEW; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 78650638887     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md8122871     Document Type: Review

References (122)

1. Ojewole, E.; Mackraj, I.; Naidoo, P.; Govender, T. Exploring the use of novel drug delivery systems for antiretroviral drugs. Eur. J. Pharm. Biopharm. 2008, 70, 697-710.
2. Govender, T.; Ojewole, E.; Naidoo, P. Polymeric nanoparticles for enhancing antiretroviral drug therapy. Drug Deliv. 2008, 15, 493-501.
3. Clavel, F.; Hance, A.J. HIV drug resistance. N. Engl. J. Med. 2004, 350, 1023-1035.
4. Lee, S.A.; Hong, S.K.; Suh, C.I.; Oh, M.H.; Park, J.H.; Choi, B.W.; Park, S.W.; Paik, S.Y. Anti-HIV-1 efficacy of extracts from medicinal plants. J. Microbiol. 2010, 48, 249-252.
5. Tantillo, C.; Ding, J.; Jacobo-Molina, A.; Nanni, R.G.; Boyer, P.L.; Hughes, S.H.; Pauwels, R.; Andries, K.; Janssen, P.A.J.; Arnold, E. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 1994, 243, 369-387.
6. Lipsky, J.J. Antiretroviral drugs for AIDS. Lancet 1996, 348, 800-803.
7. Tzileleka, L.A.; Vagias, C.; Roussis, V. Natural products with anti-HIV activity from marine organisms. Curr. Top. Med. Chem. 2003; 3, 1512-1535.
8. Singh, I.P.; Bharate, S.B.; Bhutani, K.K. Anti-HIV natural products. Curr. Sci. 2005, 89, 269-290.
9. Schaeffer, D.J.; Krylov, V.S. Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotox. Environ. Safe. 2000, 45, 208-227.
10. Vlietinck, A.J.; De Bruyne, T.; Apers, S.; Pieters, L.A. Plantderived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta. Med. 1998, 64, 97-109.
11. De Clercq, E. Current lead natural products for the chemotherapy of human immuno deficiency virus infection. Med. Res. Rev. 2000, 20, 323-349.
12. Kong, J.M.; Goh, N.K.; Chia, L.S.; Chia, T.F. Recent advances in traditional plant drugs and orchids. Acta Pharmacol. Sin. 2003, 24, 7-21.
13. Wang, R.R.; Gu, Q.; Wang, Y.H.; Zhang, X.M.; Yang, L.M.; Zhou, J.; Chen, J.J.; Zheng, Y.T. Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis. J. Ethnopharmacol. 2008, 17, 249-256.
14. Hupfeld, J.; Efferth, T. Drug resistance of human immunodeficiency virus and overcoming it by natural products. In Vivo 2009, 23, 1-6.
15. Aneiros, A.; Garateix, A. Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 2004, 803, 41-53.
16. Wijesekara, I.; Kim, S.K. Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry. Mar. Drugs 2010, 8, 1080-1093.
17. Pomponi, S.A. The oceans and human health: the discovery and development of marine-derived drugs. Oceonogrophy 2001, 14, 78-87.
18. Targett, N.M.; Arnold, T.M. Predicting the effects of brown algal phlorotannins on marine herbivores in tropical and temperate oceans. J. Phycol. 1998, 34, 195-205.
19. Shibata, T.; Kawaguchi, S.; Hama, Y.; Inagaki, M.; Yamaguchi, K.; Nakamura, T. Local and chemical distribution of phlorotannins in brown algae. J. Appl. Phycol. 2004, 16, 291-296.
20. Ahn, G.N.; Kim, K.N.; Cha, S.H.; Song, C.B.; Lee, J.; Heo, M.S.; Yeo, I.K.; Lee, N.H.; Jee, Y.H.; Kim, J.S.; Heu, M.S.; Jeon, Y.J. Antioxidant activities of phlorotannins purified from Ecklonia cava on free radical scavenging using ESR and H2O2-mediated DNA damage. Eur. Food Res. Technol. 2007, 226, 71-79.
21. Singh, I.P.; Bharate, S.B. Phloroglucinol compounds of natural origin. Nat. Prod. Rep. 2006, 23, 558-591.
22. Glombitza, K.W.; Li, S.M. Hydroxyphlorethols from the brown alga Carpophyllum maschalocarpum. Phytochemistry 1991, 30, 2741-2745.
23. La Barre, S.; Potin, P.; Leblanc, C.; Delage, L. The halogenated metabolism of brown algae (Phaeophyta), its biological importance and its environmental significance. Mar. Drugs 2010, 8, 988-1010.
24. Ahn, M.J.; Yoon, K.D.; Min, S.Y.; Lee, J.S.; Kim, J.H.; Kim, T.G.; Kim, S.H.; Kim, N.G.; Huh, H.; Kim, J. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol. Pharm. Bull. 2004, 27, 544-547.
25. Ahn, M.J.; Yoon, K.D.; Kim, C.Y.; Kim, J.H.; Shin, C.G.; Kim, J. Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown alga, Ishige okamurae. Phytother. Res. 2006, 20, 711-713.
26. Artan, M.; Li, Y.; Karadeniz, F.; Lee, S.H.; Kim, M.M.; Kim, S.K. Anti-HIV-1 activity of phloroglucinol derivative, 6,6-bieckol, from Eckloniacava. Bioorg. Med. Chem. 2008, 16, 7921-7926.
27. Carroll, S.S.; Olsen, D.B.; Bennett, C.D.; Gotlib, L; Graham, D.J.; Condraq, J.H.; Stern, A.M.; Shafer, J.A.; Kuo, L.C. Inhibition of HIV- I reverse transcriptase by pyridinone derivatives. J. Biol. Chem. 1993, 268, 276-281.
28. Zhang, H.; Vrang, L.; Backbro, K.; Lind, P.; Sahlberg, C.; Unge, T.; Oberg, B. Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127. Antivir. Res. 1995, 28, 331-342.
29. Ngo, D.N.; Kim, M.M.; Kim, S.K. Chitin oligosaccharides inhibit oxidative stress in live cells. Carbohydr. Polym. 2008, 74, 228-234.
30. Shahidi, F.; Arachchi, J.K.V.; Jeon, Y.J. Food applications of chitin and chitosans. Trends Food Sci. Technol. 1999, 10, 37-51.
31. Kim, S.K.; Nghiep, N.D.; Rajapakse, N. Therapeutic prospectives of chitin, chitosan and their derivatives. J. Chitin Chitosan 2006, 11, 1-10.
32. Jayakumar, R.; New, N.; Nagagama, H.; Furuike, T.; Tamura, H. Synthesis, characterization and biospecific degradation behavior of sulfated chitin. Macromol. Symp. 2008, 264, 163-167.
33. Suwan, J.; Zhang, Z.; Li, B.; Vongchan, P.; Meepowpan, P.; Zhang, F.; Mousa, S.A.; Mousa, S.; Premanode, B.; Kongtawelert, P.; Linhardt, R.J. Sulfonation of papain-treated chitosan and its mechanism for anticoagulant activity. Carbohydr. Res. 2009, 344, 1190-1196.
34. He, Q.; Ao, Q.; Wang, A.; Gong, Y.; Zhao, N.; Zhang, X. In vitro cytotoxicity and protein drug release properties of chitosan/heparin microspheres. Tsinghua Sci. Technol. 2007, 12, 361-365.
35. Thierry, B.; Merhi, Y.; Silver, J.; Tabrizian, M. Biodegradable membrane-covered stent from chitosan-based polymers. J. Biomed. Mater. Res. A 2005, 75, 556-566.
36. Prabaharan, M.; Reis, R.L.; Mano, J.F. Carboxymethyl chitosan-graft- phosphatidylethanolamine: Amphiphilic matrices for controlled drug delivery. React. Funct. Polym. 2007, 67, 43-52.
37. Jayakumar, R.; Nwe, N.; Tokura, S.; Tamura, H. Sulfated chitin and chitosan as novel biomaterials. Int. J. Biol. Macromol. 2007, 40, 175-181.
38. Saiki, I.; Murata, J.; Nakajima, M.; Tokura, S.; Azuma, I. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells. Cancer Res. 1990, 50, 3631-3637.
39. Vasyukova, N.I.; Chalenko, G.I.; Gerasimova, N.G.; Perekhod, E.A.; Ozeretskovskaya, O.L.; Irina, A.V.; Varlamov, V.P.; Albulov, A.I. Chitin and chitosan derivatives as elicitors of potato resistance to late blight. Appl. Biochem. Micro. 2000, 36, 372-376.
40. Xing, R.; Liu, S.; Yu, H.; Zhang, Q.; Li, Z.; Li, P. Preparation of low-molecular-weight and highsulfate- content chitosans under microwave radiation and their potential antioxidant activity in vitro. Carbohyd. Res. 2004, 339, 2515-2519.
41. Sosa, M.A.; Fazely, F.; Koch, J.A.; Vercellotti, S.V.; Ruprecht, R.M. N-carboxymethylchitosan- N,O-sulfate as an anti-HIV-1 agent. Biochem. Biophys. Res. Commun. 1991, 174, 489-496.
42. Nishimura, S.I.; Kai, H.; Shinada, K.; Yoshida, T.; Tokura, S.; Kurita, K.; Nakashima, H.; Yamamoto, N.; Uryu, T. Regioselective syntheses of sulfated polysaccharides: specific anti-HIV- 1 activity of novel chitin sulfates. Carbohydr. Res. 1998, 306, 427-433.
43. Lee, D.S.; Kim, Y.M.; Lee, M.S.; Ahn, C.B.; Jung, W.K.; Je, J.Y. Synergistic effects between aminoethyl-chitosans and β-lactams against methicillin-resistant Staphylococcus aureus (MRSA). Bioorg. Med. Chem. Lett. 2010, 20, 975-978.
44. Artan, M.; Karadeniz, F.; Kim, M.M.; Kim, S.K. Chitosan derivatives as HIV-1 inhibitors. J. Biotechnol. 2008, 136S, S527-S540.
45. Dou, J.L.; Tan, C.Y.; Du, Y.G.; Bai, X.F.; Wang, K.Y.; Ma, X.J. Effects of chitooligosaccharides on rabbit neutrophils in vitro. Carbohydr. Polym. 2007, 69, 209-213.
46. Jeon, Y.J.; Kim, S.K. Continuous production of chitooligosaccharides using a dual reactor system. Process Biochem. 2000, 35, 623-632.
47. Jeon, Y.J.; Kim, S.K. Production of chitooligosaccharides using ultrafiltration membrane reactor and their antibacterial activity. Carbohydr. Polym. 2000, 41, 133-141.
48. Yang, E.J.; Kim, J.G.; Kim, J.Y.; Kim S.C.; Lee N.H.; Hyun C.G. Anti-inflammatory effect of chitosan oligosaccharides in RAW 264.7 cells. Cent. Eur. J. Biol. 2010, 5, 95-102.
49. Chae, S.Y.; Jang, M.K.; Nah, J.W. Influence of molecular weight on oral absorption of water soluble chitosans. J. Control. Release 2005, 102, 383-394.
50. Hong, S.P.; Kim, M.H.; Oh, S.W.; Han, C.H.; Kim, Y.H. ACE inhibitory and antihypertensive effect of chitosan oligosaccharides in SHR. Korean J. Food Sci. Technol. 1998, 30, 1476-1479.
51. Park, P.J.; Je, J.Y.; Kim, S.K. Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J. Agric. Food Chem. 2003, 51, 4624-4627.
52. Park, P.J.; Lee, H.K.; Kim, S.K. Preparation of hetero- chitooligosaccharides and their antimicrobial activity on Vibrio parahaemolyticus. J. Microbiol. Biotechnol. 2004, 14, 41-47.
53. Shen, K.T.; Chen, M.H.; Chan, H.Y.; Jeng, J.H.; Wang, Y.J. Inhibitory effects of chitooligosaccharides on tumor growth and metastasis. Food Chem. Toxicol. 2009, 47, 1864-1871.
54. Jeon, Y.J.; Kim, S.K. Antitumor activity of chitosan oligosaccharides produced in ultrafiltration membrane reactor system. J. Microbiol. Biotechnol. 2002, 12, 503-507.
55. Jeon, Y.J.; Kim, S.K. Potential immuno-stimulating effect of antitumoral fraction of chitosan oligosaccharides. J. Chitin Chitosan 2001, 6, 163-167.
56. Liu, B.; Liu, W.S.; Han, B.Q.; Sun, Y.Y. Antidibetic effects of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World J. Gastroenterol. 2007, 13, 725-731.
57. Kim, K.N.; Joo, E.S.; Kim, K.I.; Kim, S.K.; Yang, H.P.; Jeon, Y.J. Effect of chitosan oligosaccharides on cholesterol level and antioxidant enzyme activities in hypercholesterolemic rat. J. Korean Soc. Food Sci. Nutr. 2005, 34, 36-41.
58. Miura, T.; Usami, M.; Tsuura, Y.; Ishida, H.; Seino, Y. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. Biol. Pharm. Bull. 1995, 18, 1623-1625.
59. Yoon, N.Y.; Ngo, D.N.; Kim, S.K. Acetylcholinesterase inhibitory activity of novel chitooligosaccharide derivatives. Carbohydr. Polym. 2009, 78, 869-872.
60. Park, P.J.; Je, J.Y.; Jung, W.K.; Kim, S.K. Anticoagulant activity of heterochitosans and their oligosaccharide sulfates. Eur. Food Res. Technol. 2004, 219, 529-533.
61. Cho, E.J.; Rahman, A.; Kim, S.W.; Baek, Y.M.; Hwang, H.J.; Oh, J.Y.; Hwang, H.S.; Lee, S.K.; Yun, J.W. Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J. Microbiol. Biotechnol. 2008, 18, 80-87.
62. Artan, M.; Karadeniz, F.; Karagozlu, M.Z.; Kim, M.M.; Kim, S.K. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydr. Res. 2010, 345, 656-662.
63. Vijayavel, K.; Anbuselvam, C.; Balasubramanian, M.P. Free radical scavenging activity of the marine mangrove Rhizophora apiculata bark extract with reference to naphthalene induced mitochondrial dysfunction. Chem. Biol. Interact. 2006, 163, 170-175.
64. Alban, S.; Franz, G. Partial synthetic glucan sulfates as potential new antithrombotics: a review. Biomacromolecules 2001, 2, 354-361.
65. Costa, L.S.; Fidelis, G.P.; Cordeiro, S.L.; Oliveira, R.M.; Sabry, D.A.; Camara, R.B.G.; Nobre, L.T.D.B.; Costa, M.S.S.P.; Almeida-Lima, J.; Farias, E.H.C.; Leite, E.L.; Rocha, H.A.O. Biological activities of sulfated polysaccharides from tropical seaweeds. Biomed. Pharmacother. 2010, 64, 21-28.
66. Ley, K.; Cerrito, M.; Arfors, K.E. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am. J. Physiol. Heart Circ. Physiol. 1991, 260, H1667-H1673.
67. Majdoub, H.; Ben Mansour, M.; Chaubet, F.; Roudesli, M.S.; Maaroufi, R.M. Anticoagulant activity of a sulfated polysaccharide from the green alga Arthrospira platensis. Biochim. Biophys. Acta. 2009, 1790, 1377-1381.
68. Synytsya, A.; Kim, W.J.; Kim, S.M.; Pohl, R.; Synytsya, A.; Kvasnicka, F.; Copikova, J.; Park, Y.I. Structure and antitumor activity of fucoidan isolated from sporophyll of Korean seaweed Undaria pinnatifida. Carbohydr. Polym. 2010, 81, 41-48.
69. Na, Y.S.; Kim, W.J.; Kim, S.M.; Park, J.W.; Lee, S.M.; Kim, S.O.; Synytsya, A.; Park, Y.I. Purification, characterization and immunostimulating activity of water-soluble polysaccharide isolated from Capsosiphon fulvescens. Int. Immunopharmacol. 2010, 10, 364-370.
70. Witvrouw, M.; De Clercq, E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol. 1997, 29, 497-511. (Pubitemid 27421412)
71. Adhikari, U.; Mateu, C.G.; Chattopadhyay, K.; Pujol, C.A.; Damonte, E.B.; Ray, B. Structure and antiviral activity of sulfated fucans from Stoechospermum marginatum. Phytochemistry 2006, 67, 2474-2482.
72. Damonte, E.B.; Matulewicz, M.C.; Cerezo, A.S. Sulfated seaweed polysaccharides as antiviral agents. Curr. Med. Chem. 2004, 11, 2399-2419.
73. Luscher-Mattil, M. Polyanions-a lost chance in the fight against HIV and other virus diseases? Antivir. Chem. Chemoth. 2000, 11, 249-259.
74. Chattopadhyay, N.; Ghosh, T.; Sinha, S.; Chattopadhyay, K.; Karmakar, P.; Ray, B. Polysaccharides from Turbinaria conoides: Structural features and antioxidant capacity. Food Chem. 2010, 118, 823-829.
75. Mandal, P.; Mateu, C.G.; Chattopadhyay, K.; Pujol, C.A.; Damonte, E.B.; Ray, B. Structural features and antiviral activity of sulfated fucans from the brown seaweed Cystoseira indica. Antivir. Chem. Chemother. 2007, 18, 153-162.
76. Mandal, P.; Pujol, C.A.; Carlucci, M.J.; Chattopadhyay, K.; Damonte, E.B.; Ray, B. Sulfated xylomannan of Scinaia hetai: Isolation, structural features and antiviral activity. Phytochemistry 2008, 69, 2193-2199.
77. Bourgougnon, N.; Lahaye, M.; Quemener, B.; Chermann, J.C.; Rimbert, M.; Cormaci, M.; Furnari, G.; Komprobst, J.M. Annual variation in composition and in vitro anti-HIV-1 activity of the sulfated glucuronogalactan from Schizymenia dubyi (Rhodophyta, Gigartinales). J. App. Phycol. 1996, 8, 155-161.
78. Riccio, R.; Kinnel, R.B.; Bifulco, G.; Scheuer, P.J. Kakelokelose, a sulfated mannose polysaccharide with anti-HIV activity from the pacific tunicate Didemnum molle. Tetrahedron Lett. 1996, 37, 1979-1982.
79. Amornrut, C.; Toida. T.; Imanari, T.; Woo, E.R.; Park, H.; Linhardt, R.; Wu, S.J.; Kim, Y.S. A new sulfated β-galactan from clams with anti-HIV activity. Carbohyd. Res. 1999, 321, 121-127.
80. Meiyu, G.; Fuchuan, L.; Xianliang, X.; Jing, L.; Zuowei, Y.; Huashi, G. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule. Antivir. Res. 2003, 59, 127-135.
81. Liu, H.; Geng, M.; Xin, X.; Li, F.; Zhang, Z.; Li, J.; Ding, J. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities. Glycobiology 2005, 15, 501-510.
82. Lee, J.B.; Hayashi, K.; Hirata, M.; Kuroda, E.; Suzuki, E.; Kubo, Y.; Hayashi, T. Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deep-sea water in Toyama bay. Biol. Pharm. Bull. 2006, 29, 2135-2139.
83. Wang, S.C., Bligh, S.W.A.; Shi, S.S.; Wang, Z.T.; Hu, Z.B.; Crowder, J.; Branford-White, C.; Vella, C. Structural features and anti-HIV-1 activity of novel polysaccharides from red algae Grateloupia longifolia and Grateloupia filicina. Int. J. Biol. Macromol. 2007, 41, 369-375.
84. Queiroz, K.C.S.; Medeiros, V.P.; Queiroz, L.S.; Abreu, L.R.D.; Rocha, H.A.O.; Ferreira, C.V.; Juca, M.B.; Aoyama, H.; Leite, E.L. Inhibition of reverse transcriptase activity of HIV by polysaccharides of brown algae. Biomed. Pharmacother. 2008, 62, 303-307.
85. Trinchero, J.; Ponce, N.M.A.; Cordoba, O.L.; Flores, M.L.; Pampuro, S.; Stortz, C.A.; Salomon, H.; Turk, G. Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis. Phytother. Res. 2009, 23, 707-712.
86. Miao, B.; Li, J.; Fu, X.; Gan, L.; Xin, X.; Geng, M. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits T cell apoptosis by combating oxidative damage of mitochondria. Mol. Pharmacol. 2005, 68, 1716-1727.
87. Sato, T.; Hori, K. Cloning, expression, and characterization of a novel anti-HIV lectin from the cultured cyanobacterium, Oscillatoria agardhii. Fish Sci. 2009, 75, 743-753.
88. Geyer, H.; Holschbach, C.; Hunsmann, G.; Schneider, J. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 1988, 263, 11760-11767.
89. Balzarini, J. Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? Antivir. Chem. Chemother. 2007, 18, 1-11.
90. Balzarini, J. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat. Rev. Microbiol. 2007, 5, 583-597.
91. Balzarini, J.; Laethem, K.V.; Daelemans, D.; Hatse, S.; Bugatti, A.; Rusnati, M.; Igarashi, Y.; Oki, T.; Schols, D. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus. J. Virol. 2007, 81, 362-373.
92. Mori, T.; O'Keefe, B.R.; Sowder, R.C., II; Bringans, S.; Gardella, R.; Berg, S.; Cochran, P.; Turpin, J.A.; Buckheit, R.W., Jr.; McMahon, J.B.; Boyd, M.R. Isolation and characterization of Griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 2005, 280, 9345-9353.
93. Wang, J.H.; Kong, J.; Li, W.; Molchanova, V.; Chikalovets, I.; Belogortseva, N.; Luk'yanov, P.; Zheng, Y.T. A β-galactose-specific lectin isolated from the marine worm Chaetopterus variopedatus possesses anti-HIV-1 activity. Comp. Biochem. Physiol. 2006, 142, 111-117.
94. Molchanova, V.; Chikalovets, I.; Chernikov, O.; Belogortseva, N.; Li, W.; Wang, J.H.; Ou Yang, D.Y.; Zheng, Y.T.; Lukyanov, P. A new lectin from the sea worm Serpula vermicularis: Isolation, characterization and anti-HIV activity. Comp. Biochem. Physiol. 2007, 145, 184-193.
95. Luk'yanov, P.A.; Chernikov, O.V.; Kobelev, S.S.; Chikalovets, I.V.; Molchanova, V.I.; Li, W. Carbohydrate-Binding Proteins of Marine Invertebrates. Russ. J. Bioorg. Chem. 2007, 33, 161-169.
96. Je, J.Y.; Qian, Z.J.; Lee, S.H.; Byun, H.G.; Kim, S.K. Purification and antioxidant properties of bigeye tuna (Thunnus obesus) dark muscle peptide on free radical-mediated oxidation systems. J. Med. Food 2008, 11, 629-637.
97. Sheih, I.C.; Fang, T.J.; Wu, T.K. Isolation and characterization of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste. Food Chem. 2009, 115, 279-284.
98. Slizyte, R.; Mozuraityte, R.; Martinez-Alvarez, O.; Falch, E.; Fouchereau-Peron, M.; Rustad, T. Functional, bioactive and antioxidative properties of hydrolysates obtained from cod (Gadus morhua) backbones. Process Biochem. 2009, 44, 668-677.
99. Suetsuna, K.; Chen, J.R. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar. Biotechnol. 2001, 3, 305-309.
100. Zhao, Y.; Li, B.; Liu, Z.; Dong, S.; Zhao, X.; Zeng, M. Antihypertensive effect and purification of an ACE inhibitory peptide from sea cucumber gelatin hydrolysate. Process Biochem. 2007, 42, 1586-1591.
101. Simpson, B.K.; Nayeri, G.; Yaylayan, V.; Ashie, I.N. A. Enzymatic hydrolysis of shrimp meat. Food Chem. 1998, 61, 131-138.
102. Korhonen, H.; Pihlanto, A. Bioactive peptides: Production and functionality. Int. Dairy J. 2006, 16, 945-960.
103. Pihlanto-Leppala, A. Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends Food Sci. Technol. 2001, 11, 347-356.
104. Byun, H.G.; Kim, S.K. Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska Pollack (Theragra chalcogramma) skin. Process Biochem. 2001, 36, 1155-1162.
105. Kim, S.Y.; Je, J.Y.; Kim, S.K. Purification and characterization of antioxidant peptide from hoki (Johnius balengerii) frame protein by gastrointestinal digestion. J. Nutr. Biochem. 2007, 18, 31-38.
106. Mendis, E.; Rajapakse, N.; Kim, S.K. Antioxidant properties of a radical-scavenging peptide purified from enzymatically prepared fish skin gelatin hydrolysate. J. Agric. Food Chem. 2005, 53, 581-587.
107. Jo, H.Y.; Jung, W.K.; Kim, S.K. Purification and characterization of a novel anticoagulant peptide from marine echiuroid worm, Urechis unicinctus. Process Biochem. 2008, 43, 179-184.
108. Rajapakse, N.; Jung, W.K.; Mendis, E.; Moon, S.H.; Kim, S.K. A novel anticoagulant purified from fish protein hydrolysate inhibits factor XIIa and platelet aggregation. Life Sci. 2005, 76, 2607-2619.
109. Liu, Z.; Dong, S.; Xu, J.; Zeng, M.; Song, H.; Zhao, Y. Production of cysteine-rich antimicrobial peptide by digestion of oyster (Crassostrea gigas) with alcalase and bromelin. Food Control 2008, 19, 231-235.
110. Stensvag, K.; Haug, T.; Sperstad, S.V.; Rekdal, O.; Indrevoll, B.; Styrvold, O.B. Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. Dev. Comp. Immuno. 2008, 32, 275-285.
111. Lee, T.G.; Maruyama, S. Isolation of HIV-1 protease-inhibiting peptides from Thermolysin hydrolysate of oyster proteins. Biochem. Bioph. Res. Co. 1998, 253, 604-608.
112. Zampella, A.; Valeria D'Auria, M.; Paloma, L.G.; Casapullo, A.; Minale, L.; Debitus, C.; Henin, Y. Callipeltin A, an anti-HIV cyclic depsipeptide from the new Caledonian lithistida sponge Callipelta sp. J. Am. Chem. Soc. 1996, 118, 6202-6209.
113. Ford, P.W.; Gustafson, K.R.; McKee, T.C.; Shigematsu, N; Maurizi, L.K.; Pannell, L.K.; Williams, D.E.; Dilip de Silva, E.; Lassota, P.; Allen, T.M.; Soest, R.V.; Andersen, R.J.; Boyd, M.R. Papuamides A-D, HIV-inhibitory and cytotoxic depsipeptides from the sponges Theonella mirabilis and Theonella swinhoei collected in Papua new guinea. J. Am. Chem. Soc. 1999, 121, 5899-5909.
114. Rashid, M.A.; Gustafson, K.R.; Cartner, L.K.; Shigematsu, N.; Pannell, L.K.; Boyd, M.R. Microspinosamide, a new HIV-inhibitory cyclic depsipeptide from the marine sponge Sidonops microspinosa. J. Nat. Prod. 2001, 64, 117-121.
115. Oku, N.; Gustafson, K.R.; Cartner, L.K.; Wilson, J.A.; Shigematsu, N.; Hess, S.; Pannell, L.K.; Boyd, M.R.; McMahon, J.B. Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua new guinea marine sponge Neamphius huxleyi. J. Nat. Prod. 2004, 67, 1407-1411.
116. Plaza, A.; Gustchina, E.; Baker, H.L.; Kelly, M.; Bewley, C.A. Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion. J. Nat. Prod. 2007, 70, 1753-1760.
117. Plaza, A.; Bifulco, G.; Keffer, J.L.; Lloyd, J.R.; Baker, H.L.; Bewley, C.A. Celebesides A-C and Theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. J. Org. Chem. 2009, 74, 504-512.
118. Zampella, A.; Sepe, V.; Luciano, P.; Bellotta, F.; Monti, M.C.; D'Auria, M.V.; Jepsen, T.; Petek, S.; Adeline, M.T.; Laprévôte, O.; Aubertin, A.M.; Debitus, C.; Poupat, C.; Ahond, A. Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp. J. Org. Chem. 2008, 73, 5319-5327.
119. Aneiros, A.; Garateix, A. Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J. Chromatogr. B 2004, 803, 41-53.
120. Andjelic, C.D.; Planelles, V.; Barrows, L.R. Characterizing the anti-HIV activity of Papuamide A. Mar. Drugs 2008, 6, 528-549.
121. Bhadury, P.; Mohammad, B.T.; Wright, P.C. The current status of natural products from marine fungi and their potential as anti-infective agents. J. Ind. Microbiol. Biotechnol. 2006, 33, 325-337.
122. Yasuhara-Bella, J.; Lu, Y. Marine compounds and their antiviral activities. Antiviral Res. 2010, 86, 231-240.